The same R&D number means opposite things depending on whether the stock has just won or lost.
Earlier work found that a high R&D-to-market-value ratio predicts higher future returns, but that ratio has market value in the denominator, so it cannot separate R&D intensity from “the stock has fallen recently.” Maletic splits R&D into two distinct signals — the level (R&D scaled by assets) and the change (year-on-year growth) — and interacts each with past one-year return.
The two interactions carry opposite signs. A high R&D level pays off after a bad year: a firm that has just performed poorly and still refuses to cut research is making a credible statement the market discounts too heavily. A rising R&D budget pays off after a good year: ramping spend is only believed when management has already shown it can pick winners.
The practical reading is that R&D is not one number. Past performance flips its meaning, and the combination — not either component alone — is what predicts. After controlling for both interactions, the older R&D-to-market-value anomaly still survives, so at least one further story remains unexplained.
Source paper
Maletic, M. (2019). R&D Investments, Past Returns, and the Cross-Section of Stock Returns. Working paper — Tilburg University / Bank of Slovenia.
SSRN 3178186 · version of 26 September 2019
Personal reading note. Written while studying the paper — not peer reviewed, not a replication, and not a substitute for the source. Every claim above belongs to the authors; any error in restating it is mine. Follow the link.